Northpond Ventures III GP, LLC - 07 Feb 2024 Form 3 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role: 10%+ Owner
Signature: Northpond Ventures III GP, LLC, By: /s/ Patrick Smerkers, Chief Financial Officer
Issuer symbol: KYTX
Transactions as of: 07 Feb 2024
Net transactions value: $0
Form type: 3
Filing time: 07 Feb 2024, 20:30:16 UTC
Next filing: 12 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	KYTX	Series B Preferred Stock							07 Feb 2024	Common Stock	2,805,426		By: Northpond Ventures III, LP	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares of Series B Convertible Preferred Stock, par value $0.00001 per share (the "Series B Preferred Stock"), of Kyverna Therapeutics, Inc. (the "Issuer") will automatically convert on a 4.5511-for-1 basis into shares of the Issuer's common stock, par value $0.00001 per share (the "Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Preferred Stock has no expiration date.
F2	Northpond Ventures III GP, LLC ("Northpond III LLC") is the general partner of Northpond Ventures III, LP ("Northpond Fund III"), and Michael P. Rubin is the managing member of Northpond III LLC. As a result, each of Northpond III LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund III. Each of Northpond III LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's respective pecuniary interest therein, if any.

Content

All shares of Series B Convertible Preferred Stock, par value $0.00001 per share (the "Series B Preferred Stock"), of Kyverna Therapeutics, Inc. (the "Issuer") will automatically convert on a 4.5511-for-1 basis into shares of the Issuer's common stock, par value $0.00001 per share (the "Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Preferred Stock has no expiration date.

Northpond Ventures III GP, LLC ("Northpond III LLC") is the general partner of Northpond Ventures III, LP ("Northpond Fund III"), and Michael P. Rubin is the managing member of Northpond III LLC. As a result, each of Northpond III LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund III. Each of Northpond III LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's respective pecuniary interest therein, if any.